Biotechnology News HYCAMTIN Search

| Biotechnology feed | All feeds

BioNews
Biotechnology, Pharmaceutical and Life Science News

Search Results

Documents 1-4 out of 4 found

Current Search: hycamtin: 4

Summary of opinion (initial authorisation) Topotecan Hospira topotecan
the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Topotecan Hospira 4mg/4ml, concentrate for solution for infusion intended for the treatment of...

Therapeutics Daily: Mar 19 2010 5:37PM
Matching: hycamtin

Find similar documents

Pharma Live: Mar 19 2010 4:45PM
Matching: hycamtin

Find similar documents

Calsed to be Decision Resources' proprietary clinical gold standard status in 2013 for extensive disease SCLC
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that Celgene/Nippon Kayaku's Calsed earns Decision Resources' proprietary clinical gold standard status in 2013 for the treatment of...

PharmaBiz: Jan 20 2010 2:10PM
Matching: hycamtin

Find similar documents

Celgene/Nippon Kayaku's Calsed Will Become Decision Resources' New Clinical Gold Standard in 2013 for the Treatment of Extensive-Disease Small-Cell Lung Cancer
See more news releases in: Health Care & Hospitals, Infectious Disease Control, Medical Pharmaceuticals, Pharmaceuticals, New Products & Services Surveyed Oncologists Look for a Drug That Can Improve Median Overall Survival in Patients, According to a...

PR Newswire: Jan 18 2010 1:48PM
Matching: hycamtin

Find similar documents

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.